EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A dual-targeted drug inhibits cardiac ryanodine receptor Ca 2+ leak but activates SERCA2a Ca 2+ uptake

Jörg W Wegener iD, Gyuzel Y Mitronova iD, Lina ElShareif iD, Christine Quentin iD, Vladimir Belov, Tatiana Pochechueva iD, Gerd Hasenfuss iD, Lutz Ackermann, Stephan E Lehnart iD

Life Science Alliance · 2024

DOI: 10.26508/lsa.202302278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Jörg W Wegener und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Pulmonology, Heart Research Center Göttingen, University Medical Center of Göttingen (UMG), Göttingen, Germany joerg.weg…. Hauptthemen laut MEDLINE: Dantrolene, Ryanodine Receptor Calcium Release Channel. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Zentrum für Herz-Kreislaufforschung, Deutsche Forschungsgemeinschaft, Germany’s Excellence Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the heart, genetic or acquired mishandling of diastolic [Ca 2+ ] by ryanodine receptor type 2 (RyR2) overactivity correlates with risks of arrhythmia and sudden cardiac death. Strategies to avoid these risks include decrease of Ca 2+ release by drugs modulating RyR2 activity or increase in Ca 2+ uptake by drugs modulating SR Ca 2+ ATPase (SERCA2a) activity. Here, we combine these strategies by developing experimental compounds that act simultaneously on both processes. Our screening efforts identified the new 1,4-benzothiazepine derivative GM1869 as a promising compound. Consequently, we comparatively studied the effects of the known RyR2 modulators Dantrolene and S36 together with GM1869 on RyR2 and SERCA2a activity in cardiomyocytes from wild type and arrhythmia-susceptible RyR2 R2474S/+ mice by confocal live-cell imaging. All drugs reduced RyR2-mediated Ca 2+ spark frequency but only GM1869 accelerated SERCA2a-mediated decay of Ca 2+ transients in murine and human cardiomyocytes. Our data indicate that S36 and GM1869 are more suitable than dantrolene to directly modulate RyR2 activity, especially in RyR2 R2474S/+ mice. Remarkably, GM1869 may represent a new dual-acting lead compound for maintenance of diastolic [Ca 2+ ].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DantroleneRyanodine Receptor Calcium Release ChannelAnimalsHumansMiceArrhythmias, CardiacBiological TransportMyocytes, Cardiac

Substanzen

DantroleneRyanodine Receptor Calcium Release Channel

Autor:innen und Institutionen

  • Department of Cardiology and Pulmonology, Heart Research Center Göttingen, University Medical Center of Göttingen (UMG), Göttingen, Germany joerg.wegener@med.uni-goettingen.de.
  • DZHK (German Centre for Cardiovascular Research), Partner Site Göttingen, Göttingen, Germany.
  • Department of NanoBiophotonics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Department of Cardiology and Pulmonology, Heart Research Center Göttingen, University Medical Center of Göttingen (UMG), Göttingen, Germany.
  • Georg-August University of Göttingen, Institute of Organic and Biomolecular Chemistry, Göttingen, Germany.
  • Department of Cardiology and Pulmonology, Heart Research Center Göttingen, University Medical Center of Göttingen (UMG), Göttingen, Germany slehnart@med.uni-goettingen.de.

ORCID-Profile: Jörg W Wegener, Gyuzel Y Mitronova, Lina ElShareif, Christine Quentin, Tatiana Pochechueva, Gerd Hasenfuss, Stephan E Lehnart

Förderung

  • Deutsches Zentrum für Herz-Kreislaufforschung
  • Deutsche Forschungsgemeinschaft
  • Germany’s Excellence Initiative

Zitieren

APA

Wegener, J. W., Mitronova, G. Y., ElShareif, L., Quentin, C., Belov, V., Pochechueva, T., Hasenfuss, G., Ackermann, L., & Lehnart, S. E. (2024). A dual-targeted drug inhibits cardiac ryanodine receptor Ca 2+ leak but activates SERCA2a Ca 2+ uptake. Life Science Alliance. https://doi.org/10.26508/lsa.202302278

Vancouver

Wegener JW, Mitronova GY, ElShareif L, Quentin C, Belov V, Pochechueva T, et al. A dual-targeted drug inhibits cardiac ryanodine receptor Ca 2+ leak but activates SERCA2a Ca 2+ uptake. Life Science Alliance. 2024. doi:10.26508/lsa.202302278

BibTeX
@article{Wegener2024,
  author = {Wegener, Jörg W and Mitronova, Gyuzel Y and ElShareif, Lina and Quentin, Christine and Belov, Vladimir and Pochechueva, Tatiana and Hasenfuss, Gerd and Ackermann, Lutz and Lehnart, Stephan E},
  title = {A dual-targeted drug inhibits cardiac ryanodine receptor Ca 2+ leak but activates SERCA2a Ca 2+ uptake},
  journal = {Life Science Alliance},
  year = {2024},
  doi = {10.26508/lsa.202302278}
}
Kostenlos starten →